We are live on ! Find out more
HEC

Hudson Executive Capital Portfolio holdings

AUM $151M
1-Year Est. Return 60.14%
This Fund
S&P 500
This Quarter Est. Return
+7.98%
1 Year Est. Return
+60.14%
3 Year Est. Return
+143.92%
5 Year Est. Return
+104.85%
10 Year Est. Return
+677.02%
AUM
$829M
AUM Growth
-$10.1M
Cap. Flow
-$13.9M
Cap. Flow %
-1.68%
Top 10 Hldgs %
100%
Holding
6
New
Increased
1
Reduced
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
AKYA
Akoya BioSciences
AKYA
+$14.2M

Sector Composition

Rank Sector Weight
1 Financials 85.35%
2 Technology 11.76%
3 Healthcare 1.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DB icon
1
Deutsche Bank
DB
$65.3B
$707M 85.35%
67,389,676
CTLP
2
DELISTED
Cantaloupe
CTLP
$97.5M 11.76%
12,245,860
TALK icon
3
Talkspace
TALK
$873M
$12.4M 1.5%
11,340,600
VRAY
4
DELISTED
ViewRay, Inc.
VRAY
$5.55M 0.67%
15,752,093
AKYA
5
DELISTED
Akoya BioSciences
AKYA
-1,736,017
Closed -$14.2M

Similar funds

Hudson Executive Capital's Q2 2023 Portfolio in Review

As of Q2 2023, Hudson Executive Capital held 6 positions worth $829M, down 1.2% from $839M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Hudson Executive Capital's Q2 2023 filing shows 1 increased and 1 closed positions. The largest sale was Akoya BioSciences, an estimated $14.2M.

By sector, the portfolio is most concentrated in Financials at 85% of assets, up from 82% a quarter earlier, followed by Technology and Healthcare.

  • Hudson Executive Capital fully exited Akoya BioSciences in Q2 2023, selling an estimated $14.2M.
  • Hudson Executive Capital's ten largest holdings make up 100% of its $829M portfolio in Q2 2023.
  • Hudson Executive Capital opened 0 new positions and closed 1 in Q2 2023.
  • Hudson Executive Capital's portfolio value fell 1.2% quarter-over-quarter to $829M.

Based on Hudson Executive Capital's 13F filing for Q2 2023, filed 14 Aug 2023.